BIOVIT — Bio Vitos Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK48.15m
- SEK45.07m
- SEK3.00m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 18.9 | 6.37 | 8.79 | 3.19 | 3.07 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.39 | 0.693 | 0.494 | 0.786 | 1.13 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 19.4 | 8.29 | 11.1 | 5.22 | 5.11 |
Net Property, Plant And Equipment | 1.32 | 2.3 | 1.84 | 1.32 | 0.806 |
Net Intangible Assets | |||||
Total Assets | 47.9 | 35.8 | 35.5 | 26.4 | 33.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.67 | 2.26 | 1.96 | 1.53 | 1.01 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.88 | 2.26 | 1.96 | 1.53 | 1.01 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 45.1 | 33.5 | 33.5 | 24.9 | 32.9 |
Total Liabilities & Shareholders' Equity | 47.9 | 35.8 | 35.5 | 26.4 | 33.9 |
Total Common Shares Outstanding |